Anti-Spike RBD Antibody (Sotrovimab)
Catalog No.
F1030
Anti-Spike RBD Antibody (Sotrovimab)
Featured Products
Sotrovimab (VIR 7831) is a human IgG1κ pan-coronavirus monoclonal antibody that neutralizes SARS-CoV-2, SARS-CoV-1, and multiple other coronaviruses. Sotrovimab is based on S309, has a longer half-life, and has high bioavailability in the respiratory mucosa. Sotrovimab may lead to immune-mediated viral clearance and prevent the development of Covid-19 early in the course of the disease.
146.06 kDa
Dry ice
2423014-07-5
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
sotrovimab, WBP2275
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Human
Unconjugated
Monoclonal
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Spike RBD
Please avoid freeze-thaw cycles.